Phase 1 Tumor Associated Lymph Node T Cell Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

Advanced Solid TumorImmunotherapyTumor Associated Lymph Node T Cell+1 more

Guangzhou FineImmune Biotechnology Co., LTD.32 enrolled1 locationNCT06716619

Recruiting

Phase 1

Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors

Advanced Solid TumorImmunotherapyTumor Associated Lymph Node T Cell

Guangzhou FineImmune Biotechnology Co., LTD.23 enrolled1 locationNCT06302062